TB2012.33
Trust Board Meeting: Thursday 3 May 2012
TB2012.33
Title
Operational Performance Report Month 12
Status
A paper for noting by the Board outlining current
performance and the issues impacting the on the
integrity and quality of the data.
History
This is a regular report to the Board.
Board Lead(s)
Mr Paul Brennan, Director of Clinical Services
Key purpose
Strategy
Assurance
TB2012.33_OUH Operational Performance Report Month 12
Policy
Performance
1
Oxford University Hospitals
TB2012.32
Summary
The Board is asked to note the following key points on the attached data sheet: 1 The Board Report continues to be provided on a restricted basis as the Teams work to ‘clean up’ the data following the EPR transfer. It should be noted that all performance figures contained in the performance report are validated and reflect actual performance with the exception of the 4 hour standard. The 4 hour monthly figure is derived from the year to date position achieved prior to the EPR implementation. 2 C‐Diff and MRSA performance standards have been achieved for 2011/2012. 3 Cancer and 18 week RTT performance remains on track with all performance standards achieved in month 12 with the exception of the surgical subsequent treatment standard. This is however a provisional figure which is subject to further validation. 4 Delayed transfers of care remain a major concern for the Trust and the 9.65% figure for month 12 is well in excess of the 3.5% standard, though represents a slight reduction from month 11. To contextualise this the table below shows the OUH and system wide reported delays for month 12. Week Ending 4th March 11th March 18th March 25th March 1st April Reported Delays OUH Oxford System 117 95 101 99 92 198 184 201 182 180 The position for the week ending 22nd April 2012 was 184 system wide delays. TB2012.33_OUH Operational Performance Report Month 12
2
Service Performance Reporting template 2011-12
ORH
2011-12
2.07%
2.30%
56
60
68
79
88
87
12.20%
0.00%
15 minutes
60
60 minutes
88
4.84%
June
July
April
2.37%
March
3.42%
1.94%
2.49%
February
3.52%
3.64%
97.6%
January
November
93.9%
Q3
95.13%
3.31%
5%
95.3%
December
October
95.7%
5%
94.6%
Q1
95.47%
95.6%
95.6%
95.6%
95.6%
NA
NA
Q4 (To date)
95.6%
NA
NA
NA
NA
NA
NA
68
NA
NA
NA
NA
87
NA
NA
NA
NA
NA
NA
NA
1.12%
8.33%
6.33%
0
Assessed from Quarter 2 2011-12 onwards
Cancelled ops - breaches of 28 days
readmission guarantee as % of
cancelled ops
MRSA
5%
C Diff
137
RTT - admitted - 95th percentile
<=23
RTT - non-admitted - 95th
percentile
September
Unplanned reattendance rate
Unplanned re-attendance at A&E
within 7 days of original attendance
Time to initial Assessment 95th
Percentile
Time to treatment-Median
96.5%
95%
discharge **
Four-hour maximum wait in A&E from
arrival to admission, transfer or
discharge- Quarterly **
Left without being seen rate
94.9%
96.9%
Q2
96.33%
2.90%
May
Four-hour maximum wait in A&E from
arrival to admission, transfer or
August
Performing
Thresholds
Performance Framework for Acute Trusts 2011-12
4.17%
6
0.00%
0.00%
0
1
0
0
0
1
2
0
0
0
0
5
5
8
7
14
9
14
8
8
7
13
5
23.9
24.9
22.2
22.4
22.1
22.3
22.0
21.9*
21.4*
19.2*
22.0*
21.6*
<=18.3
RTT - incomplete - 95th percentile
<=28
RTT - admitted - 90% in 18 weeks
90%
RTT - non-admitted - 95% in 18 weeks
95%
2 week GP referral to 1st outpatient
93%
2 week GP referral to 1st outpatient breast symptoms
31 day second or subsequent
treatment - surgery ~
31 day second or subsequent
treatment - drug ~
31 day diagnosis to treatment for all
cancers ~
Proportion of patients waiting no
more than 31 days for second or
subsequent cancer treatment
(radiotherapy treatments)
93%
62 day referral to treatment from
screening
90%
62 day referral to treatment from
hospital specialist
62 days urgent GP referral to
treatment of all cancers
85%
Patients that have spent more than
90% of their stay in hospital on a
stroke unit
Delayed transfers of care
80%
15.7
15.6
16.3
16.3
16.4
16.0
16.2
16.0*
16.2*
17.5*
16.9*
17.2*
21.6
16.6
16.1
16.2
16.0
17.0
16.4
17.5*
17.3*
17.3*
17.8*
17.2*
87%
89%
90%
90%
91%
91%
90%
91%*
91%*
92%*
90%*
90%*
97%
97%
96%
97%
97%
97%
97%
97%*
97%*
96%*
96%*
96%*
91.6%
92.6%
96.5%
96.9%
99.1%
98.2%
98.6%
98.5%
98.1%
95.3%
98.1%
96.1%
74.5%
95.3%
98.9%
100.0%
99.4%
100.0%
99.0%
95.9%
98.7%
100.0%
100.0%
100.0%
94%
98.2%
93.5%
98.5%
96.4%
100.0%
97.5%
100.0%
95.2%
98.1%
96.8%
98.6%
90.9%
100.0%
97.8%
100.0%
98.6%
100.0%
100.0%
100.0%
97.6%
100.0%
100.0%
97.7%
100.0%
97.0%
95.9%
96.4%
97.1%
99.1%
97.8%
97.7%
98.4%
98.3%
96.9%
98.7%
98.1%
93.1%
93.9%
97.7%
96.2%
97.6%
96.6%
87.2%
97.4%
99.0%
97.1%
97.4%
98.6%
98%
96%
94%
78.3%
NA
87.5%
NA
87.0%
100.0%
85.7%
92.3%
84.6%
95.7%
94.1%
85.7%
100.0%
94.1%
100.0%
NA
NA
NA
NA
NA
NA
NA
NA
NA
85%
81.4%
84.9%
88.0%
86.0%
86.5%
90.8%
88.1%
89.6%
86.0%
90.2%
86.0%
87.6%
72.1%
72.9%
86.7%
86.4%
82.0%
81.1%
90.5%
80.8%
86.9%
86.7%
85.9%
87.1%
7.00%
7.68%
5.12%
9.41%
10.64%
8.70%
11.49%
11.10%
10.84%
9.10%
10.68%
9.65%
11
11
11
11
3.50%
* These figures relate to post merger OUH perfromance
** December 2011 to March 2012 (incl) - Due to data quality issues the Trust submitted average year to date figures for ED performance. The DoH are currently querying the validity of this.
12
12
12
12
1
12
11
11